Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria
Clinical trial NCT07505472 · RECRUITING
Trial details
- NCT number
- NCT07505472
- Sponsor
- The First Hospital of Jilin University
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-23
- Primary completion
- 2029-12-31
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.